Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 1
2016 3
2017 2
2018 2
2019 8
2020 7
2021 12
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Thiotepa-melphalan myeloablative therapy for high-risk neuroblastoma.
Yamazaki F, Yamasaki K, Kiyotani C, Hashii Y, Shioda Y, Hara J, Matsumoto K. Yamazaki F, et al. Among authors: yamasaki k. Pediatr Blood Cancer. 2021 Jun;68(6):e28896. doi: 10.1002/pbc.28896. Epub 2021 Mar 31. Pediatr Blood Cancer. 2021. PMID: 33788375
Radiation-induced osteosarcoma in a patient with DICER1 syndrome.
Tanimura K, Nakano Y, Sato-Otsubo A, Yamasaki K, Fukushima H, Tanaka M, Yoshioka T, Okita H, Kunihiro N, Sakamoto H, Inoue T, Fujisaki H, Hara J. Tanimura K, et al. Among authors: yamasaki k. Pediatr Blood Cancer. 2022 Dec;69(12):e29782. doi: 10.1002/pbc.29782. Epub 2022 May 20. Pediatr Blood Cancer. 2022. PMID: 35593689 No abstract available.
Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study.
Fukuoka K, Kurihara J, Shofuda T, Kagawa N, Yamasaki K, Ando R, Ishida J, Kanamori M, Kawamura A, Park YS, Kiyotani C, Akai T, Keino D, Miyairi Y, Sasaki A, Hirato J, Inoue T, Nakazawa A, Koh K, Nishikawa R, Date I, Nagane M, Ichimura K, Kanemura Y. Fukuoka K, et al. Among authors: yamasaki k. Acta Neuropathol Commun. 2023 Sep 25;11(1):153. doi: 10.1186/s40478-023-01652-4. Acta Neuropathol Commun. 2023. PMID: 37749662 Free PMC article.
Low tumor cell content predicts favorable prognosis in germinoma patients.
Takami H, Satomi K, Fukuoka K, Fukushima S, Matsushita Y, Yamasaki K, Nakamura T, Tanaka S, Mukasa A, Saito N, Suzuki T, Yanagisawa T, Nakamura H, Sugiyama K, Tamura K, Maehara T, Nakada M, Nonaka M, Asai A, Yokogami K, Takeshima H, Iuchi T, Kanemura Y, Kobayashi K, Nagane M, Kurozumi K, Yoshimoto K, Matsuda M, Matsumura A, Hirose Y, Tokuyama T, Kumabe T, Narita Y, Shibui S, Nakazato Y, Nishikawa R, Matsutani M, Ichimura K. Takami H, et al. Among authors: yamasaki k. Neurooncol Adv. 2021 Aug 10;3(1):vdab110. doi: 10.1093/noajnl/vdab110. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34549182 Free PMC article.
The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors.
Nakamura H, Takami H, Yanagisawa T, Kumabe T, Fujimaki T, Arakawa Y, Karasawa K, Terashima K, Yokoo H, Fukuoka K, Sonoda Y, Sakurada K, Mineharu Y, Soejima T, Fujii M, Shinojima N, Hara J, Yamasaki K, Fujimura J, Yamasaki F, Takahashi M, Suzuki T, Sato I, Nishikawa R, Sugiyama K. Nakamura H, et al. Among authors: yamasaki k. Neuro Oncol. 2022 Apr 1;24(4):503-515. doi: 10.1093/neuonc/noab242. Neuro Oncol. 2022. PMID: 34671804 Free PMC article.
40 results